EcoDrugPlus

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSMMSG00000023805
Gene Symbol: IDH2
1 Cross references
261 Possible Orthologues:

Kallikrein B1

Ensembl ID : ENSMMSG00000020367
Gene Symbol: KLKB1
1 Cross references
206 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSMMSG00000015254
Gene Symbol: KEAP1
1 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSMMSG00000021120
Gene Symbol: KDR
1 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSMMSG00000010787
Gene Symbol: KIF11
1 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSMMSG00000022465
Gene Symbol: KIF5B
1 Cross references
281 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSMMSG00000024150
Gene Symbol: LTA4H
1 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSMMSG00000006732
Gene Symbol: LTB4R
1 Cross references
140 Possible Orthologues:

Leukotriene B4 Receptor 2

Ensembl ID : ENSMMSG00000006782
Gene Symbol: LTB4R2
1 Cross references
236 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSMMSG00000013026
Gene Symbol: LOXL2
1 Cross references
287 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSMMSG00000018782
Gene Symbol: MIF
1 Cross references
218 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSMMSG00000018684
Gene Symbol: MST1R
1 Cross references
266 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).